Compare AAME & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AAME | DRIO |
|---|---|---|
| Founded | 1968 | 2011 |
| Country | United States | United States |
| Employees | N/A | 165 |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.2M | 60.6M |
| IPO Year | 1995 | 2013 |
| Metric | AAME | DRIO |
|---|---|---|
| Price | $2.20 | $8.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 4.5K | ★ 7.6K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | 0.22 | ★ 1.25 |
| Revenue | ★ $188,227,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | $10.64 | ★ $6.64 |
| Revenue Growth | 0.77 | ★ 43.02 |
| 52 Week Low | $1.64 | $0.38 |
| 52 Week High | $3.71 | $17.74 |
| Indicator | AAME | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 34.88 | 56.11 |
| Support Level | $2.15 | $6.16 |
| Resistance Level | $3.16 | $9.46 |
| Average True Range (ATR) | 0.09 | 0.44 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 0.00 | 72.37 |
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.